The role of advanced glycation end products on dyslipidemia

HIGHLIGHTS

  • who: Jelena Vekic et al. from the Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, University of Palermo, Palermo, Italy have published the research: The Role of Advanced Glycation End Products on Dyslipidemia, in the Journal: Metabolites 2023, 77 of 28/Dec/2022
  • what: 10 of 14
  • how: In this respect the experimental data showed that statins may prevent the oxidation of glycated LDL particles and reduce levels of atherogenic small dense LDL while the results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) trial demonstrated that atorvastatin treatment . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?